Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUPENTIXOL Cause Therapeutic product effect variable? 144 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Therapeutic product effect variable have been filed in association with FLUPENTIXOL. This represents 12.6% of all adverse event reports for FLUPENTIXOL.

144
Reports of Therapeutic product effect variable with FLUPENTIXOL
12.6%
of all FLUPENTIXOL reports
0
Deaths
144
Hospitalizations

How Dangerous Is Therapeutic product effect variable From FLUPENTIXOL?

Of the 144 reports, 144 (100.0%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Therapeutic product effect variable Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUPENTIXOL. However, 144 reports have been filed with the FAERS database.

What Other Side Effects Does FLUPENTIXOL Cause?

Drug ineffective (632) Suicide attempt (522) Dyskinesia (372) Blood glucose increased (365) Sedation (362) Anosognosia (356) Sexual dysfunction (355) Blood prolactin abnormal (353) Disturbance in social behaviour (351) Metabolic disorder (351)

What Other Drugs Cause Therapeutic product effect variable?

CARBIDOPA\LEVODOPA (316) LEVODOPA (298) RIMEGEPANT (177) GABAPENTIN (166) CLOZAPINE (157) DICLOFENAC (153) OLANZAPINE (150) FLUOXETINE (149) ARIPIPRAZOLE (148) AMISULPRIDE (147)

Which FLUPENTIXOL Alternatives Have Lower Therapeutic product effect variable Risk?

FLUPENTIXOL vs FLUPENTIXOL DECANOATE FLUPENTIXOL vs FLUPHENAZINE FLUPENTIXOL vs FLUPHENAZINE DECANOATE FLUPENTIXOL vs FLUPIRTINE FLUPENTIXOL vs FLURAZEPAM

Related Pages

FLUPENTIXOL Full Profile All Therapeutic product effect variable Reports All Drugs Causing Therapeutic product effect variable FLUPENTIXOL Demographics